Needham Maintains Buy on Dentsply Sirona, Raises Price Target to $42
Portfolio Pulse from Benzinga Newsdesk
Needham analyst David Saxon has reaffirmed a Buy rating on Dentsply Sirona (NASDAQ:XRAY) and increased the price target from $35 to $42.
January 09, 2024 | 4:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst David Saxon maintains a Buy rating on Dentsply Sirona and raises the price target from $35 to $42, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst typically signals a positive forecast for the company's stock performance and can lead to increased investor confidence. As the price target has been raised significantly, this suggests a strong belief in the company's potential for growth or improved financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100